Coronado's bowel disease treatment fails in mid-stage study

(Reuters) - Coronado Biosciences Inc said its treatment for Crohn's disease, a type of inflammatory bowel disease, failed the main goal of improving patients' response to the disease in a mid-stage study, sending its shares down 70 percent. The treatment, Trichuris suis ova, comprised eggs taken from a pig whipworm. It is intended to modulate a patient's immune system and prevent it from attacking the body's own tissues and organs. Coronado's partner Dr. Falk Pharma GmbH is conducting a mid-stage study in Europe, testing three doses of TSO in active Crohn's disease. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/coronados-bowel-disease-treatment-fails-mid-stage-study-134727882--finance.html